Health Trials

Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)

1

Review clinical trials related to Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting

This study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting

Participants needed: 124
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Peking University Cancer Hospital & InstituteUpdated: Jul 9, 2026
Eligibility criteria

18 years of age or older, of either gender [+7]

Read more